Sequence-Based Discovery Demonstrates That Fixed Light Chain Human Transgenic Rats Produce a Diverse Repertoire of Antigen-Specific Antibodies-Reference-Cited by-同舟云学术

Sequence-Based Discovery Demonstrates That Fixed Light Chain Human Transgenic Rats Produce a Diverse Repertoire of Antigen-Specific Antibodies

Published:2018-04-24 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Harris Katherine E.,Aldred Shelley Force,Davison Laura M.,Ogana Heather Anne N.,Boudreau Andrew,Brüggemann Marianne,Osborn Michael,Ma Biao,Buelow Benjamin,Clarke Starlynn C.,Dang Kevin H.,Iyer Suhasini,Jorgensen Brett,Pham Duy T.,Pratap Payal P.,Rangaswamy Udaya S.,Schellenberger Ute,van Schooten Wim C.,Ugamraj Harshad S.,Vafa Omid,Buelow Roland,Trinklein Nathan D.

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference34 articles.

1. Development trends for human monoclonal antibody therapeutics;Nelson;Nat Rev Drug discov,2010

2. Antibody therapeutics in cancer;Sliwkowski;Science,2013

3. Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery;Lee;Nat Biotechnol,2014

4. Antigen-specific human antibodies from mice comprising four distinct genetic modifications;Lonberg;Nature,1994

5. A repertoire of monoclonal antibodies with human heavy chains from transgenic mice;Brüggemann;Proc Natl Acad Sci U S A,1989

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facilitating high throughput bispecific antibody production and potential applications within biopharmaceutical discovery workflows;mAbs;2024-02-21

2. An Engineered Mouse Model That Generates a Diverse Repertoire of Endogenous, High-Affinity Common Light Chain Antibodies;Antibodies;2024-02-08

3. Humanized single-domain antibody targeting HER2 enhances function of chimeric antigen receptor T cells;Frontiers in Immunology;2023-11-07

4. Application of germline antibody features to vaccine development, antibody discovery, antibody optimization and disease diagnosis;Biotechnology Advances;2023-07

5. Anti-BCMA novel therapies for multiple myeloma;Cancer Drug Resistance;2023